Theravance Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments.
CEORick E. Winningham
CEORick E. Winningham
Employees97
Employees97
HeadquartersSouth San, California
HeadquartersSouth San, California
Founded2013
Founded2013
Employees97
Employees97
TBPH Key Statistics
Market cap939.47M
Market cap939.47M
Price-Earnings ratio32.98
Price-Earnings ratio32.98
Dividend yield—
Dividend yield—
Average volume570.18K
Average volume570.18K
High today$19.61
High today$19.61
Low today$18.48
Low today$18.48
Open price$18.78
Open price$18.78
Volume245.16K
Volume245.16K
52 Week high$20.33
52 Week high$20.33
52 Week low$7.90
52 Week low$7.90
Stock Snapshot
The current Theravance Biopharma(TBPH) stock price is $19.59, with a market capitalization of 939.47M. The stock trades at a price-to-earnings (P/E) ratio of 32.98.
On 2025-12-06, Theravance Biopharma(TBPH) stock moved within a range of $18.48 to $19.61. With shares now at $19.59, the stock is trading +6.0% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 245.16K, compared to an average daily volume of 570.18K.
Over the past 52 weeks, Theravance Biopharma(TBPH) stock has traded between a high of $20.33 and a low of $7.90.
Over the past 52 weeks, Theravance Biopharma(TBPH) stock has traded between a high of $20.33 and a low of $7.90.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own TBPH. This list is generated using Robinhood data, and it’s not a recommendation.